Anti-proliferative effect of cytohesin inhibition in gefitinib-resistant lung cancer cells.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), such as gefitinib, have been proven to efficiently inhibit the proliferation of a subset of non small-cell lung cancers (NSCLC). Unfortunately, the majority of NSCLC expressing wild type EGFR is primarily resistant to EGFR-TKI...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science (PLoS)
2012-01-01
|
| Col·lecció: | PLoS ONE |
| Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22815959/?tool=EBI |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|